Joseph Gunnar & Co. PIONEERS 2017 Conference :: Moleculin Biotech, Inc. (MBRX)

Skip to content

About
Mission
Technology
- Technology Overview
- COVID-19
- Annamycin
- WP1066
- WP1122
- WP1732
- WP1234
- WP1220
- Expanded Access
Pipeline
Partnerships
Partnering Inquiries
Science
News
- Press Releases
- Media Archive
Investors

Main Menu

Moleculin Biotech

A clinical-stage pharmaceutical company focused on the treatment of highly resistant cancers and viruses.

Acute Myeloid Leukemia
COVID-19
Skin Cancer
Pancreatic Cancer
Brain Tumors

Shareholder Letter 2020
Pancreatic Cancer
Acute Myeloid Leukemia
Brain Tumors
Skin Cancer

IR Calendar

Overview
News / Events
Financial Info
Annual Report and Proxy
Stock Data
SEC Filings
Governance
Investor Tools

News / Events
Overview
Press Releases
IR Calendar
Email Alerts
FAQs

Joseph Gunnar & Co. PIONEERS 2017 Conference

Mandarin Oriental Hotel, New York, NY

May 2, 2017 • 2:30pm EDT

Webcast

Contact Us

Moleculin Biotech, Inc.
5300 Memorial Drive, Suite 950
Houston, TX, 77007

info@moleculin.com
(713) 300-5160

Follow Us

Find us on:

Facebook Twitter

Copyright 2021 Moleculin. All Rights Reserved.

Go to Top